Investment Firm
Overview
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Oct 02, 2017
Series B
Highlights
N/A
Location
Social
N/A
Investor Lead
N/A
Participant Investors
4
KSQ Therapeutics raised $76000000 on 2017-10-02 in Series B
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Company Funding History
2
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Sep 28, 2018 | Series C - KSQ Therapeutics | 8 | - | 80.0M |
Oct 02, 2017 | Series B - KSQ Therapeutics | 4 | - | 76.0M |
Recent Activity
There is no recent news or activity for this profile.